BQ Blue's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BloombergQuint's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Max Life reported a mixed quarter as annual premium equivalent growth remains modest, impacted by sluggish growth in protection/non-participating segment, while PAR/unit link investment plan witnessed healthy growth.
As a result, protection mix moderated over H1 FY22.
On the distribution front, the bancassurance/proprietary channel supported Max Financials' growth momentum.
Value of new business margin expanded sharply to 29.1% in Q2 FY22 (versus 19.7% in Q1 FY21), supported by improving product mix and base effect of high opex in Q1 FY22.
We expect value of new business margin to sustain at 25-26% and estimate 21% annual premium equivalent compound annual growth rate over FY21-24E.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
